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collagen plug was placed intravascular, surgical repair because of haematomas was
needed once in the VS group and twice in the AS group respectively. There were no sig-
nificant difference between the two devices in terms of total complications.
Conclusion: The application of collagen based VCD after PCI does not increase the rate
of complications and can be safely and effectively performed. The complication rates are
equivalent to previously published rates with manual compression.
1046-167 Incidence and Predictors of Left Ventricular 
Dysfunction in Patients With Takayasu or Giant Cell 
Aortitis
David H. Pfizenmaier, II, Faisal O. Al Atawi, Yamil Castillo, Krishnaswamy 
Chandrasekaran, Leslie T. Cooper, Mayo Clinic, Rochester, MN
Background: Left ventricular dysfunction (LVD) in patients with aortitis has been
described in few studies. The incidence and predictors of LVD in patients with angio-
graphically confirmed Takayasu or Giant Cell aortitis (TA/GCA) is not known.
Methods: We identified 87 patients with angiographically confirmed TA/GCA. All patients
underwent transthoracic echocardiographic studies that were subsequently reviewed in a
blinded fashion. LVD was defined as an ejection fraction (LVEF) less than 50%.
Results: The study population was 84 % Caucasian (73/87), 91 % female (79/87), and
had a mean age of disease onset of 30 years. The average LVEF was 56.5 % (n=87).
The average time between symptom onset and diagnosis was 40 months, and the aver-
age time between symptom onset and echocardiography was 81 months. Of the 87
patients, 19.5% (17) had an LVEF less than 50 % (mean of 37 % +/- 7.9 %). LVD was
present in 43 % (10/23) of patients with versus 11 % (7/64) of patients without aortic arch
involvement (p = 0.0017). LVD was found in 27 % (12/44) of patients with versus 12 % (5/
43) of patients without descending aortic involvement (p=0.07). Aortic regurgitation was
present in 76 % (13/17) of patients with versus 36 % (25/70) of patients without LVD
(p=0.002). Patients with LVD had a median of 2 (range 1-4) involved aortic segments
compared to a median of 1 (range 1-4) among those without LVD (p=0.008). The follow-
ing factors were not associated with the presence of LVD: aortic thickness, the number of
involved extra-aortic vessels, aneurysm, hypertension, diabetes, tobacco use, sedimen-
tation rate, leukocyte count, hemoglobin, retinopathy, and progressive course of arteritis.
Conclusion: In TA/GCA with aortitis, LVD was associated with aortic regurgitation, aortic
arch involvement, and with the greater extent of aortic involvement. Descending aortic
arch involvement was associated with LVD with borderline significance. These data sug-
gest that hemodynamic and immunologic factors both contribute to LVD in this popula-
tion.
1046-168 Global Renal Revasculatization Preserves Renal 
Function in Diabetic and Nondiabetic Patients With 
Renal Insufficiency
Srinivasa P. Potluri, Rajesh Subramanian, Jose A. Silva, Stephen R. Ramee, Tyrone J. 
Collins, James Stephen Jenkins, Christopher J. White, Ochsner Clinic Foundation, New 
Orleans, LA
Background: Patients with diabetes and ischemic nephropathy progress to end stage
renal disease at a faster rate compared to non-diabetic patients. Whether diabetic
patients (DM) obtain similar benefits in renal function preservation as non-diabetic
patients (NDM) with renal artery stenting is unknown.
Methods: The renal function of 46 consecutive patients with bilateral renal stenosis or
solitary renal artery stenosis (13 DM; 33 NDM) and renal insufficiency (serum creatinine
1.5 to 4.0mg/dl) were analyzed for blood pressure, number of medications, and by con-
structing the pre and Post procedures 1/creatinine over time slopes for all patients.
Results: All patients had deterioration of renal function prior to intervention. At a mean
follow-up of 23 months post intervention, the slope of reciprocal of creatinine over time
showed improvement in both groups. (Figure)
Conclusion: Renal artery stenting is equally beneficial in preservation of renal function in
DM and NDM patients with impaired renal function and atherosclerotic global renal artery
stenosis. 
1046-169 Renal Artery Stenting for Blood Pressure Control Is 
Equally Effective in Unilateral and Bilateral Renal Artery 
Stenosis
Khaldoon Alaswad, Tyrone J. Collins, Stephen J. Ramee, James Stephen Jenkins, 
Christopher J. White, Ochsner Clinic Foundation, New Orleans, LA
Introduction: Hypervolemia is the pathophysiology of bilateral renal artery stenosis (RAS)
while hyper-reninemia is the pathophysiology of unilateral RAS in patients with renovas-
cular hypertension. It is not known if bilateral stenting for bilateral RAS is similar to unilat-
eral stenting for unilateral RAS.
Methods: We reviewed the blood pressure (BP) at baseline and one month in 176 con-
secutive patients: after unilateral stenting in 110 patients with unilateral RAS and bilateral
stenting in 66 patients with bilateral RAS. All treated arteries had > 50% atherosclerotic
stenosis by angiography. All patients had uncontrolled hypertension despite therapy with
two or more BP medications. Patients with a solitary (single) kidney, on dialysis, or kidney
transplant were excluded.
Results: BP, renal function, and demographics were similar at baseline. One month fol-
lowing renal intervention, both groups demonstrated similar improvement in BP (see
table. Note: *p <0.0001, †p=0.017 compared to baseline).
Conclusion: The BP response after renal stent placement is significant and similar in
magnitude in patients with bilateral vs. unilateral RAS.
1046-170 Surgical Treatment of Ascending Aortic Aneurysms in 
Patients With Giant Cell Aortitis
Alok Mathur, Kenton J. Zehr, Thomas A. Orszulak, Charles J. Mullany, Hartzell V. Schaff, 
Mayo Clinic, Rochester, MN
Background: Giant cell aortitis (GCA) is a rare cause of an ascending aortic aneurysm.
We present an 8 year experience with surgical repair.
Methods: 37 pt (29:8M, age 69.6+/-9.5 years) were operated from 1995-2002. 27%(10)
had a history of steroid treatment for temporal arteritis or polymyalgia rheumatica, 8.9+/-
3.9 years prior. 51%(19) patients had +3-+4 aortic regurgitation. Maximal aneurysm size
was 6.1+/-0.8 cm. 81%(30) underwent replacement of the ascending aorta, 11%(4) had
a modified Bentall procedure, 5%(2) had a valve-sparing root reconstruction, and 3%(1)
had aortorrhaphy. 59(22) required 22+/-9 minutes of hypothermic circulatory arrest for
hemi or complete aortic arch repair. 70%(26) pt had concomitant procedures.
Results: There was no early mortality. Morbidity was re-exploration for bleeding in 8%(3),
stroke in 8% (3), left vocal cord paralysis in 5%(2), renal failure in 5%(2), and GI bleed in
3%(1). 32%(19) received postoperative steroid therapy. Mean follow-up was 2.8+/-2.3
years. 4-year survival was 74% (95%CI 57-94). Other descending and/or abdominal aor-
tic or great vessel aneurysms occurred in 46%(17). 4 had prior aneurysm surgery, 8 were
followed with aneurysms, and 5 underwent repair of an aneurysm in the follow-up period.
Of 8 late deaths, 3 were caused by complications of a descending thoracic aneurysm.
Conclusions: Ascending aortic aneurysms caused by GCA can involve the aorta from the
aortic root through the aortic arch. A tailored operative intervention can be done with low
morbidity and mortality. Other aneurysms of the aorta and great vessels occur in nearly
one-half of patients. Frequent surveillance of the remaining aorta is mandatory.
1046-171 Preoperative Statins Are Associated With Shorter 
Length of Stay and Improved Long Term Survival in 
Patients Undergoing Vascular Surgery
R. Parker Ward, Nicholas J. Leeper, James N. Kirkpatrick, Kim A. Williams, Roberto M. 
Lang, Lewis B. Schwartz, Tina R. Desai, University of Chicago, Chicago, IL
Background: Patients (pts) undergoing vascular surgery are at risk for perioperative car-
diovascular (CV) complications. Preoperative statin therapy has recently been associated
with decreased perioperative mortality in pts undergoing vascular surgery. Our goal was
to study the effect of preoperative statin therapy on perioperative morbidity, length of stay
(LOS), and long-term survival in pts undergoing vascular surgery. Methods: We retro-
spectively reviewed 561 consecutive infra-inguinal vascular surgeries on 446 pts
between 1995-2001. Preoperative statin and beta-blocker use, comorbidities, periopera-
tive events, and LOS were noted. Long-term survival was assessed using the Social
Security Death Index (SSDI). Results: Preoperative statins and beta-blockers were used
in 16% and 23% of surgeries, respectively. Baseline comorbidities included: CAD (59%),
CABG (19%), DM (54%), prior stroke (CVA) (5%), smoking (55%), HTN (76%), COPD
(8%), and ESRD (18%). Perioperative events included 30-day death (2.9%), 30-day CV
death (2.0%), MI (5.2%), CVA (0.9%), and major vascular events (13.4%). Statin therapy
was associated with a shorter LOS (6.4 vs 9.7 days, p<0.0001), while beta-blocker ther-
apy was not. Multivariate analysis models, adjusting for multiple surgeries within pts, and
controlling for comorbidities, age, and operative year, were employed. Independent pre-
dictors of shorter LOS were statin therapy (p=.008), absence of ESRD (p= 0.01), and
later operative year (p=0.02). Beta-blocker therapy was associated with fewer MI’s
(p=0.02), and fewer combined CV death, MI and CVA (p=0.04). Statin therapy was asso-
ciated with trends towards fewer MIs (p=0.09), and fewer combined death, MI, and CVA
Unilateral 
Baseline (n=110)
Unilateral Follow-
up (n=110)
Bilateral 
Baseline 
(n=66)
Bilateral Follow-
up (n=66)
SBP, mmHg 169±28 147±23* 172±32 148±26*
DBP mmHg 87±15 77±13* 87±15 77±13*
Mean BP 
mmHg
114±17 100±14* 115±19 101±16*
Number of 
BP Meds
2.43±0.97 2.10±0.86† 2.28±1.26 1.94±1.14
